A new study suggests that depression and GI trouble sometimes spring from the same source — low serotonin — and identifies a potential treatment that could ease both conditions simultaneously.
Findings could fundamentally change how scientists interpret the biological activities of serotonin.
Researchers have developed more than a dozen new potential drug candidates they believe have the potential to curb smoking addiction by slowing how nicotine is broken down in the body.
According to researchers, gut serotonin levels are doubled in obese people. Researchers report obesity may be characterized by an increased capacity to release and produce serotonin in the gut.
